Should all community planners start changing their approach to municipal planning and status quo infrastructures? They better really understand the market first, warns columnist James Carlini, which means high-speed broadband connectivity should trump New Urbanism as their top priority....
The Supreme Court decision in KSR International vs. Teleflex not only clarified the “obviousness” standard for patents, it sent a message about adhering to Supreme Court precedents, writes John Scheller, an attorney with Michael Best & Friedrich. In this guest column for WTN, Scheller says...
Like the Olympic games, BIO 2007 in Boston truly is an international event, as about 25 percent of the attendees are from overseas, notes columnist Michael Rosen. In this edition of Yer Biotech Blues, Rosen points to participation from Australia, Malaysia, Singapore, China, Japan, Korea,...
How does Wisconsin stack up to the nation's best biotechnology hubs? This week in Boston, the state will have plenty to thump its chest about at the annual Biotechnology Industry Organization (BIO) Convention, writes columnist Tom Still. In this edition of Inside Wisconsin, he...
The practice of software development isn't always as well defined as it could be, but there are effective methods that have been flying underneath the radar. Madison software developer Robert Merrill has a few ideas for software-intensive businesses, and he presents them in this informative...
Any business that offers or sells securities is subject to both state and federal securities laws and regulations. In this 10th component of his Early Stage series, columnist and attorney Joe Boucher breaks down the complex rules and regulations pertaining to federal securities laws....
Wisconsin bioscience companies have positioned themselves as national and international leaders in a range of industries - from molecular diagnostics to medical imaging. In this guest column, Jim Leonhart, executive vice president of the Wisconsin Biotechnology and Medical Device Association, explains how these businesses are...
States must have a good network infrastructure to build a 21st Century knowledge economy, writes columnist James Carlini. In this edition of Carlini's Comments, he warns that states which create and foster a positive platform for network infrastructure are going to capture businesses from the...
The Abbott-Thailand patent saga is more than just a dispute between an American company and a foreign government, according to columnist and physician Ogan Gurel. At stake is what former Wisconsin governor and HHS Secretary Tommy Thompson calls “the balancing act between innovation and access.”...
Are American technology and life-science businesses getting a bum rap when they take advantage of the H-1B specialty worker program? Attorney Grant Sovern thinks so, and in this guest column he defends the program and urges Congress to lift the cap on the number of...